Curis, Inc. (CRIS)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
Curis Debt to Equity Ratio : 0.2224 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2224 |
| March 31, 2026 | 0.1052 |
| December 31, 2025 | 0.2962 |
| September 30, 2025 | -2.083 |
| June 30, 2025 | -2.321 |
| March 31, 2025 | -5.199 |
| December 31, 2024 | -6.190 |
| September 30, 2024 | -4.493 |
| June 30, 2024 | -60.40 |
| March 31, 2024 | 4.503 |
| December 31, 2023 | 2.308 |
| September 30, 2023 | 1.62 |
| June 30, 2023 | 1.892 |
| March 31, 2023 | 1.396 |
| December 31, 2022 | 1.148 |
| September 30, 2022 | 0.9771 |
| June 30, 2022 | 0.8978 |
| March 31, 2022 | 0.7358 |
| December 31, 2021 | 0.6487 |
| September 30, 2021 | 0.5865 |
| June 30, 2021 | 0.5467 |
| March 31, 2021 | 0.5183 |
| December 31, 2020 | 0.5043 |
| September 30, 2020 | -2.351 |
| June 30, 2020 | -2.247 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.514 |
| December 31, 2019 | -1.847 |
| September 30, 2019 | -2.458 |
| June 30, 2019 | -3.196 |
| March 31, 2019 | -4.766 |
| December 31, 2018 | -7.892 |
| September 30, 2018 | 47.50 |
| June 30, 2018 | 5.414 |
| March 31, 2018 | 2.748 |
| December 31, 2017 | 1.732 |
| September 30, 2017 | 1.408 |
| June 30, 2017 | 4.756 |
| March 31, 2017 | 2.086 |
| December 31, 2016 | 0.6786 |
| September 30, 2016 | 0.5519 |
| June 30, 2016 | 0.4756 |
| March 31, 2016 | 0.4094 |
| December 31, 2015 | 0.3746 |
| September 30, 2015 | 0.3359 |
| June 30, 2015 | 0.3306 |
| March 31, 2015 | 0.3125 |
| December 31, 2014 | 0.9502 |
| September 30, 2014 | 0.8388 |
| June 30, 2014 | 0.7579 |
| March 31, 2014 | 0.7454 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 18.97M |
| Total Liabilities (Quarterly) | 14.28M |
| Shareholders Equity (Quarterly) | 4.695M |
| Current Ratio | 0.4917 |
| Net Debt Paydown Yield | 32.73% |